Evidence map›Paper›PMID 24345775›Full record

ArticleScientific reports2013

Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness.

Duncan Sinclair, Stu G Fillman, Maree J Webster, Cynthia Shannon Weickert

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 96 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Neurobiology of stress · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. The HPA Axis as Target for Depression.Current neuropharmacology · 2024
    Article
  16. Stress, Environment and Early Psychosis.Current neuropharmacology · 2024
    Review
  17. Article
  18. Review
  19. FKBP5 inhibitors modulate alcohol drinking and trauma-related behaviors in a model of comorbid post-traumatic stress and alcohol use disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Duncan Sinclair1] Schizophrenia Research Institute, Sydney, New South Wales, Australia [2] Neuroscience Research Australia, Sydney, New South Wales, Australia [3] School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia [4] Neuropsychiatric Signaling Program, Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania.
Stu G Fillman1] Schizophrenia Research Institute, Sydney, New South Wales, Australia [2] Neuroscience Research Australia, Sydney, New South Wales, Australia [3] School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.
Maree J WebsterStanley Medical Research Institute, Laboratory of Brain Research, 9800 Medical Center Drive, Rockville, Maryland 20850.
Cynthia Shannon Weickert1] Schizophrenia Research Institute, Sydney, New South Wales, Australia [2] Neuroscience Research Australia, Sydney, New South Wales, Australia [3] School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia.
Schizophrenia Research Institute · AUNeuroscience Research Australia · AUStanley Medical Research Institute · US

Funding

Brain Tissue Resource Centre for Alcohol ResearchR28AA012725 · NIAAA · UNIVERSITY OF SYDNEY · PI Greg Trevor Sutherland · 2012 to 2026
$7.0M
NIAAA NIH HHS R28 AA012725
6 · The paper itself

Abstract

Molecular abnormalities within the glucocorticoid receptor (GR) stress signaling pathway may confer, or reflect, susceptibility to stress in schizophrenia and bipolar disorder, but the extent of such abnormalities in the brain is not known. Using RNA-Seq and qPCR in two postmortem cohorts totaling 55 schizophrenia, 34 bipolar disorder and 55 control individuals, we identified increased FKBP5 and PTGES3 mRNA expression, and decreased BAG1 mRNA expression, in the prefrontal cortex in schizophrenia cases relative to controls (68.0% [p < 0.001], 26.0% [p < 0.01] and 12.1% [p < 0.05] respectively). We also observed increased FKBP5 and decreased BAG1 mRNA expression in bipolar disorder (47.5% [p < 0.05] and 14.9% [p < 0.005]). There were no diagnostic differences in steady-state FKBP51 protein levels, nor in HSPA1A, HSP90AA1, DNAJB1 or HSPB1 mRNA levels. GR, co-factor and chaperone mRNA levels were strongly correlated. These results reveal coordinated cortical dysregulation of FKBP5, PTGES3, BAG1 and GR genes within the glucocorticoid signaling pathway in psychotic illness.

Indexed as

AdolescentAdultAgedBase SequenceBipolar DisorderBrainDNA-Binding ProteinsFemaleHumansIntramolecular OxidoreductasesMaleMiddle AgedPolymorphism, Single NucleotidePrefrontal CortexProstaglandin-E SynthasesReceptors, GlucocorticoidBCL2-associated athanogene 1 proteinDNA-Binding ProteinsIntramolecular OxidoreductasesProstaglandin-E SynthasesPTGES3 protein, humanReceptors, GlucocorticoidRNA, MessengerTacrolimus Binding Protein 5Tacrolimus Binding ProteinsTranscription Factors

Identifiers

PMID24345775
PMCPMC3866598
OpenAlexW2049504958

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.